GoodRx Holdings, Inc.
GDRX
$4.43
-$0.045-1.01%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.61% | 7.14% | 4.03% | 2.27% | -2.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.61% | 7.14% | 4.03% | 2.27% | -2.12% |
| Cost of Revenue | -22.76% | -32.44% | -20.74% | -16.25% | -4.08% |
| Gross Profit | 8.18% | 11.23% | 6.51% | 4.17% | -1.94% |
| SG&A Expenses | 0.27% | 10.69% | 11.08% | 2.78% | -3.06% |
| Depreciation & Amortization | 14.06% | -40.51% | 3.83% | 7.32% | 12.53% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.02% | -5.09% | 3.29% | -1.55% | -3.68% |
| Operating Income | 98.31% | 287.64% | 13.57% | 90.24% | 26.56% |
| Income Before Tax | 156.61% | 87.15% | -422.35% | -75.33% | -139.21% |
| Income Tax Expenses | 132.27% | 122.94% | 97.33% | -452.54% | -586.65% |
| Earnings from Continuing Operations | 284.82% | -207.92% | -597.70% | 86.39% | 72.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 284.82% | -207.92% | -597.70% | 86.39% | 72.99% |
| EBIT | 98.31% | 287.64% | 13.57% | 90.24% | 26.56% |
| EBITDA | 29.26% | 57.72% | 14.86% | 44.61% | 26.31% |
| EPS Basic | 290.75% | -205.18% | -595.12% | 85.25% | 71.52% |
| Normalized Basic EPS | 169.46% | 1,343.75% | 27.21% | 477.42% | 83.71% |
| EPS Diluted | 269.57% | -232.65% | -764.02% | 83.69% | 70.02% |
| Normalized Diluted EPS | 167.65% | 1,350.53% | 26.57% | 476.34% | 88.37% |
| Average Basic Shares Outstanding | -6.93% | -6.09% | -4.02% | -1.83% | -0.62% |
| Average Diluted Shares Outstanding | -5.88% | -5.17% | -3.63% | -1.71% | -1.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
